<?xml version="1.0" ?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.3 20210610//EN"  "JATS-archivearticle1-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">elife</journal-id>
<journal-id journal-id-type="publisher-id">eLife</journal-id>
<journal-title-group>
<journal-title>eLife</journal-title>
</journal-title-group>
<issn publication-format="electronic" pub-type="epub">2050-084X</issn>
<publisher>
<publisher-name>eLife Sciences Publications, Ltd</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">107496</article-id>
<article-id pub-id-type="doi">10.7554/eLife.107496</article-id>
<article-id pub-id-type="doi" specific-use="version">10.7554/eLife.107496.2</article-id>
<article-version-alternatives>
<article-version article-version-type="publication-state">reviewed preprint</article-version>
<article-version article-version-type="preprint-version">1.2</article-version>
</article-version-alternatives>
<article-categories><subj-group subj-group-type="heading">
<subject>Genetics and Genomics</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>Epidemiology and Global Health</subject>
</subj-group>
</article-categories><title-group>
<article-title>Heterogenous associations of polygenic indices of 35 traits with mortality</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0910-823X</contrib-id>
<name>
<surname>Lahtinen</surname>
<given-names>Hannu</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="aff" rid="a2">2</xref>
<email>hannu.lahtinen@helsinki.fi</email>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3716-2455</contrib-id>
<name>
<surname>Kaprio</surname>
<given-names>Jaakko</given-names>
</name>
<xref ref-type="aff" rid="a3">3</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8147-240X</contrib-id>
<name>
<surname>Ganna</surname>
<given-names>Andrea</given-names>
</name>
<xref ref-type="aff" rid="a4">4</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8499-2008</contrib-id>
<name>
<surname>Korhonen</surname>
<given-names>Kaarina</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="aff" rid="a2">2</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9100-9331</contrib-id>
<name>
<surname>Lombardi</surname>
<given-names>Stefano</given-names>
</name>
<xref ref-type="aff" rid="a4">4</xref>
<xref ref-type="aff" rid="a5">5</xref>
<xref ref-type="aff" rid="a6">6</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1759-3079</contrib-id>
<name>
<surname>Silventoinen</surname>
<given-names>Karri</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9374-1438</contrib-id>
<name>
<surname>Martikainen</surname>
<given-names>Pekka</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="aff" rid="a2">2</xref>
</contrib>
    <aff id="a1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/040af2s02</institution-id><institution>Helsinki Institute for Demography and Population Health, University of Helsinki</institution></institution-wrap>, <city>Helsinki</city>, <country country="FI">Finland</country></aff>
    <aff id="a2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/040af2s02</institution-id><institution>Max Planck – University of Helsinki Center for Social Inequalities in Population Health</institution></institution-wrap>, <city>Helsinki</city>, <country country="FI">Finland</country></aff>
    <aff id="a3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/040af2s02</institution-id><institution>Institute for Molecular Medicine FIMM, University of Helsinki</institution></institution-wrap>, <city>Helsinki</city>, <country country="FI">Finland</country></aff>
    <aff id="a4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/040af2s02</institution-id><institution>FIMM, University of Helsinki</institution></institution-wrap>, <city>Helsinki</city>, <country country="FI">Finland</country></aff>
    <aff id="a5"><label>5</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/017qjec28</institution-id><institution>VATT Institute for Economic Research</institution></institution-wrap>, <city>Helsinki</city>, <country country="FI">Finland</country></aff>
    <aff id="a6"><label>6</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/029s44460</institution-id><institution>Institute of Labor Economics (IZA)</institution></institution-wrap>, <city>Bonn</city>, <country country="DE">Germany</country></aff>
</contrib-group>
<contrib-group content-type="section">
<contrib contrib-type="editor">
<name>
<surname>Franco</surname>
<given-names>Eduardo L</given-names>
</name>
<role>Reviewing Editor</role>
<aff>
<institution-wrap>
<institution-id institution-id-type="ror">https://ror.org/01pxwe438</institution-id><institution>McGill University</institution>
</institution-wrap>
<city>Montreal</city>
<country country="CA">Canada</country>
</aff>
</contrib>
<contrib contrib-type="senior_editor">
<name>
<surname>Franco</surname>
<given-names>Eduardo L</given-names>
</name>
<role>Senior Editor</role>
<aff>
<institution-wrap>
<institution-id institution-id-type="ror">https://ror.org/01pxwe438</institution-id><institution>McGill University</institution>
</institution-wrap>
<city>Montreal</city>
<country country="CA">Canada</country>
</aff>
</contrib>
</contrib-group>
<author-notes>
<fn fn-type="coi-statement"><p>Competing interests: No competing interests declared</p></fn>
</author-notes>
<pub-date date-type="original-publication" iso-8601-date="2025-08-21">
<day>21</day>
<month>08</month>
<year>2025</year>
</pub-date>
<pub-date date-type="update" iso-8601-date="2026-01-15">
<day>15</day>
<month>01</month>
<year>2026</year>
</pub-date>
<volume>14</volume>
<elocation-id>RP107496</elocation-id>
<history>
<date date-type="sent-for-review" iso-8601-date="2025-05-14">
<day>14</day>
<month>05</month>
<year>2025</year>
</date>
</history>
<pub-history>
<event>
<event-desc>Preprint posted</event-desc>
<date date-type="preprint" iso-8601-date="2025-03-14">
<day>14</day>
<month>03</month>
<year>2025</year>
</date>
<self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2025.03.14.25323952"/>
</event>
<event>
<event-desc>Reviewed preprint v1</event-desc>
<date date-type="reviewed-preprint" iso-8601-date="2025-08-21">
<day>21</day>
<month>08</month>
<year>2025</year>
</date>
<self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.107496.1"/>
<self-uri content-type="editor-report" xlink:href="https://doi.org/10.7554/eLife.107496.1.sa2">eLife Assessment</self-uri>
<self-uri content-type="referee-report" xlink:href="https://doi.org/10.7554/eLife.107496.1.sa1">Reviewer #1 (Public review):</self-uri>
<self-uri content-type="referee-report" xlink:href="https://doi.org/10.7554/eLife.107496.1.sa0">Reviewer #2 (Public review):</self-uri>
</event>
</pub-history>
<permissions>
<copyright-statement>© 2025, Lahtinen et al</copyright-statement>
<copyright-year>2025</copyright-year>
<copyright-holder>Lahtinen et al</copyright-holder>
<ali:free_to_read/>
<license xlink:href="https://creativecommons.org/licenses/by/4.0/">
<ali:license_ref>https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
<license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="elife-preprint-107496-v2.pdf"/>
<abstract>
<sec>
<title>Background</title>
<p>Polygenic indices (PGIs) of various traits abound, but knowledge remains limited on how they predict wide-ranging health indicators, including the risk of death. We investigated the associations between mortality and 35 different PGIs related to social, psychological, and behavioural traits, and typically non-fatal health conditions.</p>
</sec>
<sec>
<title>Methods</title>
<p>Data consist of Finnish adults from population-representative genetically informed epidemiological surveys (FINRISK 1992–2012, Health 2000/2011, FinHealth 2017), linked to administrative registers (N: 40,097 individuals, 5948 deaths). Within-sibship analysis was complemented with dizygotic twins from Finnish twin study cohorts (N: 10,174 individuals, 2116 deaths). We estimated Cox proportional hazards models with mortality follow-up 1995–2019.</p>
</sec>
<sec>
<title>Results</title>
<p>PGIs most strongly predictive of all-cause mortality were ever smoking (hazard ratio [HR]=1.12, 95% confidence interval [95% CI] 1.09; 1.14 per one standard deviation larger PGI), self-rated health (HR=0.90, 95% CI 0.88; 0.93), body mass index (HR=1.10, 95% CI 1.07; 1.12), educational attainment (HR=0.91, 95% CI 0.89; 0.94), depressive symptoms (HR=1.07, 95% CI 1.04; 1.10), and alcohol drinks per week (HR=1.06, 95% CI 1.04; 1.09). Within-sibship estimates were approximately consistent with the population analysis, suggesting no evidence for inflation of PGI–mortality associations by population phenomena. The investigated PGIs were typically more predictive for external than for natural causes of death. PGIs were more strongly associated with death occurring at younger ages, while among those who survived to age 80, the PGI–mortality associations were negligible.</p>
</sec>
<sec>
<title>Conclusions</title>
<p>PGIs related to the best-established mortality risk phenotypes had the strongest associations with mortality. They offer moderate additional prediction even when mutually adjusting with their phenotype.</p>
</sec>
</abstract>
<funding-group>
<award-group id="par-1">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000781</institution-id>
<institution>EC | European Research Council (ERC)</institution>
</institution-wrap>
</funding-source>
    <award-id award-id-type="doi">10.3030/101019329</award-id>
<principal-award-recipient>
<name>
<surname>Martikainen</surname>
<given-names>Pekka</given-names>
</name>
</principal-award-recipient>
</award-group>
<award-group id="par-2">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100002341</institution-id>
<institution>Research Council of Finland (AKA)</institution>
</institution-wrap>
</funding-source>
<award-id>352543-352572</award-id>
<principal-award-recipient>
<name>
<surname>Martikainen</surname>
<given-names>Pekka</given-names>
</name>
</principal-award-recipient>
</award-group>
    <award-group id="par-3">
        <funding-source>
            <institution-wrap>
                <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100002341</institution-id>
                <institution>Research Council of Finland (AKA)</institution>
            </institution-wrap>
        </funding-source>
        <award-id>345219</award-id>
        <principal-award-recipient>
            <name>
                <surname>Martikainen</surname>
                <given-names>Pekka</given-names>
            </name>
        </principal-award-recipient>
    </award-group>
    <award-group id="par-4">
        <funding-source>
            <institution-wrap>
                <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100002341</institution-id>
                <institution>Research Council of Finland (AKA)</institution>
            </institution-wrap>
        </funding-source>
        <award-id>136528219</award-id>
        <principal-award-recipient>
            <name>
                <surname>Martikainen</surname>
                <given-names>Pekka</given-names>
            </name>
        </principal-award-recipient>
    </award-group>
    <award-group id="par-5">
        <funding-source>
            <institution-wrap>
                <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100002341</institution-id>
                <institution>Research Council of Finland (AKA)</institution>
            </institution-wrap>
        </funding-source>
        <award-id>136528212</award-id>
        <principal-award-recipient>
            <name>
                <surname>Martikainen</surname>
                <given-names>Pekka</given-names>
            </name>
        </principal-award-recipient>
    </award-group>
<award-group id="par-6">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004012</institution-id>
<institution>Jane ja Aatos Erkon Säätiö (J&amp;AE)</institution>
</institution-wrap>
</funding-source>
<award-id>210046</award-id>
<principal-award-recipient>
<name>
<surname>Martikainen</surname>
<given-names>Pekka</given-names>
</name>
</principal-award-recipient>
</award-group>
<award-group id="par-7">
<funding-source>
<institution-wrap>
    <institution-id institution-id-type="ror">https://ror.org/01hhn8329</institution-id>
<institution>Max Planck Society</institution>
</institution-wrap>
</funding-source>
<award-id>5714240218</award-id>
<principal-award-recipient>
<name>
<surname>Martikainen</surname>
<given-names>Pekka</given-names>
</name>
</principal-award-recipient>
</award-group>
<award-group id="par-8">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100007797</institution-id>
<institution>Helsingin Yliopisto (HY)</institution>
</institution-wrap>
</funding-source>
<award-id>77204227</award-id>
<principal-award-recipient>
<name>
<surname>Martikainen</surname>
<given-names>Pekka</given-names>
</name>
</principal-award-recipient>
</award-group>
<award-group id="par-9">
<funding-source>
<institution-wrap>
<institution>Cities of Helsinki, Vantaa and Espoo</institution>
</institution-wrap>
</funding-source>
<award-id>4706914</award-id>
<principal-award-recipient>
<name>
<surname>Martikainen</surname>
<given-names>Pekka</given-names>
</name>
</principal-award-recipient>
</award-group>
<award-group id="par-10">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100002341</institution-id>
<institution>Research Council of Finland (AKA)</institution>
</institution-wrap>
</funding-source>
<award-id>350399</award-id>
<principal-award-recipient>
<name>
<surname>Lombardi</surname>
<given-names>Stefano</given-names>
</name>
</principal-award-recipient>
</award-group>
</funding-group>
<custom-meta-group>
<custom-meta specific-use="meta-only">
<meta-name>publishing-route</meta-name>
<meta-value>prc</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
<notes>
<notes notes-type="disclosures">
<title>Author Declarations</title><p>I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.</p><p>Yes</p><p>The details of the IRB/oversight body that provided approval or exemption for the research described are given below:</p><p>The Finnish Social and Health Data Permit Authority (Findata) has accepted the use of clinical data (THL/4725/14.02.00/2020; THL/1423/14.06.00/2022), and THL Biobank has approved the use of genetic data (THLBB2020_8; THLBB2023_51) and the data linkage to the Finnish population registers (TK-53-876-20; TK/2041/07.03.00/2023). All participants gave their informed consent.</p><p>I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.</p><p>Yes</p><p>I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).</p><p>Yes</p><p>I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.</p><p>Yes</p></notes>
<fn-group content-type="summary-of-updates">
<title>Summary of Updates:</title>
<fn fn-type="update"><p>This version has been revised to accommodate the changes recommended by the eLife reviewers. Empirical analysis has changed to include the model tests and information criteria in Supplementary Table S9 and related text in the manuscript, as well as to employ multiple-testing adjustments more widely. Additionally, the presentation and language has been edited for grammatical correctness and fluent presentation.</p></fn>
</fn-group>
</notes>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>The genome-wide association study (GWAS) literature has identified a vast number of polygenic indices (PGIs) on almost every widely-measured human phenotype<sup><xref ref-type="bibr" rid="c1">1</xref>–<xref ref-type="bibr" rid="c3">3</xref></sup>. One motivation for this endeavour has been to construct tools that may help clinical practice in disease risk prediction<sup><xref ref-type="bibr" rid="c4">4</xref>–<xref ref-type="bibr" rid="c6">6</xref></sup>. In addition, PGIs can have possible utility for health risk assessment in a more indirect manner, since they may have downstream importance in predicting health and functioning more widely beyond their immediate phenotypes, such as regarding their ability to predict all-cause mortality. Previous studies have sought genetic variants and their composites to explain mortality<sup><xref ref-type="bibr" rid="c7">7</xref></sup> or closely related concepts such as (disease-free) life-span<sup><xref ref-type="bibr" rid="c8">8</xref>,<xref ref-type="bibr" rid="c9">9</xref></sup> and biological ageing<sup><xref ref-type="bibr" rid="c10">10</xref></sup>. Some previous studies have also assessed PGI–mortality associations<sup><xref ref-type="bibr" rid="c10">10</xref>–<xref ref-type="bibr" rid="c12">12</xref></sup>. However, the existing literature covers mostly disease- or biomarker-related PGIs, and our knowledge is still limited on to what extent PGIs for social, psychological, and behavioural phenotypes or PGIs for typically non-fatal health conditions can help in mortality prediction.</p>
<p>Additionally, the state-of-the-art knowledge is scarce regarding to what extent the PGI–mortality associations stem from direct genetic effects. When the interest lies beyond merely predictive uses, the research has increasingly shown the limitations of PGIs as black-box predictors, which may include – in addition to the usually-desired direct genetic signals – population-related phenomena due to geographical stratification of ancestries, dynastic or shared environmental effects in families and kins, as well as assortative mating. Within-sibship analysis designs may alleviate such limitations, taking advantage of the fact that the genetic differences between siblings originate from the random segregation at meiosis<sup><xref ref-type="bibr" rid="c1">1</xref>,<xref ref-type="bibr" rid="c13">13</xref></sup>.</p>
<p>Another area where the knowledge on the PGI–mortality relationship is still relatively limited includes heterogenous associations with socio-demographic factors, different contributions to causes of death, as well how the associations interplay with corresponding phenotypes. The mortality risks between individuals differ substantially by their sex, age and education<sup><xref ref-type="bibr" rid="c14">14</xref>,<xref ref-type="bibr" rid="c15">15</xref></sup>, warranting an assessment on the potential heterogenous effects regarding them. It is also possible that social, psychological, and behaviour-related PGIs may matter disproportionately more for certain causes of death including accidents, suicides, and violent and alcohol-related deaths. Such ‘external’ mortality is conceptually closely connected to risky behaviour and substance use. A relevant question for their practical utility is also whether PGIs can bring additional information to predicting the risk of death in cases when information of the measured phenotype is available.</p>
<p>In this study, we address these gaps in knowledge by assessing the association between 35 different PGIs – mostly related to social, psychological, and behavioural traits or typically non-fatal health conditions – and mortality using a population-representative sample of over 40,000 Finnish individuals with up to 25 years of register-based mortality follow-up. We also assess the extent of potential population-stratification and related biases by within-sibship analysis of over 10,000 siblings. Furthermore, we examine potential heterogeneous PGI–mortality associations by sex and education, as well as for mortality occurring at different ages and separately for external and natural causes of death. Finally, we compare six PGIs that show the strongest associations with mortality (PGIs of ever smoking, body mass index [BMI], depressive symptoms, alcoholic drinks per week, educational attainment and self-rated health) and their phenotypes when mutually adjusting for each other.</p>
</sec>
<sec id="s2">
<title>Methods</title>
<sec id="s2a">
<title>Study population</title>
<p>The main (‘population’) analysis sample consists of genetically informed population surveys FINRISK rounds 1992, 1997, 2002, 2007 and 2012, as well as Health 2000/2011 and FinHealth 2017<sup><xref ref-type="bibr" rid="c16">16</xref>–<xref ref-type="bibr" rid="c18">18</xref></sup>. The response rates of these data collections varied between 65 and 93%. The genetic data followed the Sequencing Initiative Suomi protocols in the quality control and imputation procedures<sup><xref ref-type="bibr" rid="c19">19</xref>,<xref ref-type="bibr" rid="c20">20</xref></sup>. Among the initial pooled sample, 88% had genotyped data available after the quality-control procedures. These data were linked to administrative registers using pseudonymised personal identity codes, including socio-demographic and mortality information maintained by Statistics Finland. In addition to this population sample, we used a within-sibship analysis sample to assess the extent of direct and indirect genetic associations captured by the PGIs, as discussed in the introduction. Individuals in the sibling data were mainly dizygotic twins from Finnish twin cohorts: ‘old cohort’ (born before 1958), FinnTwin16 (born 1974–1979), and FinnTwin12 (1983–1987)<sup><xref ref-type="bibr" rid="c21">21</xref></sup>. These sibling data were complemented with individuals identified from the population sample as likely full siblings based on their genetic similarity (0.35&lt;Identity by descent&lt;0.80) and having an age difference of less than 18 years. They were excluded from the main population analysis to achieve non-overlapping samples.</p>
<p>The individuals were followed from (whichever was latest) 1) January of 1995, 2) July of the data collection year, or 3) the month the respondent turned 25 years. The mortality follow-up ended (whichever was earliest) at the end of 2019, or at the date of death. The analytic sample size was 40,097 individuals (564,885 person-years of follow-up) and 5948 deaths in the population analysis. The within-sibship analysis included 10,174 individuals (200,683 person-years of follow-up) in 5071 sibships and 2116 deaths.</p>
</sec>
<sec id="s2b">
<title>Variables</title>
<p>The outcome was death that occurred during the follow-up period. External (accidents, suicides, violence, and alcohol-related causes of death; International Classification of Diseases 10th revision codes: F10, G312, G4051, G621, G721, I426, K292, K70, K852, K860, O354, P043, Q860, V01–Y89; 587 deaths) and natural causes of death (other codes; 5349 deaths) were identified from the national cause of death register collected by Statistics Finland. Twelve individuals had an unknown cause of death and were excluded from the cause-specific analysis.</p>
<p>As the independent variables of main interest, we used 35 different PGIs in the Polygenic Index repository by Becker et al.<sup><xref ref-type="bibr" rid="c2">2</xref></sup>, which were mainly based on GWASes using UK Biobank and 23andMe, Inc. data samples, but also other data collections. They were tailored for the Finnish data, i.e., excluding overlapping individuals between the original GWAS and our analysis and performing linkage-disequilibrium adjustment. We used every single-trait PGI defined in the repository (except for subjective well-being, for which we were unable to obtain a meta-analysis version that excluded the overlapping samples). By limiting the researchers’ freedom in selecting the measures, this conservative strategy should increase the validity of our estimates, particularly with regards to multiple-testing adjusted p-values. The PGIs are described in Supplementary table S1 (see also <sup><xref ref-type="bibr" rid="c2">2</xref>,<xref ref-type="bibr" rid="c22">22</xref></sup>). The PGIs were standardised to have mean 0 and standard deviation (SD) 1.</p>
<p>We also measured corresponding phenotypes for the six PGIs with the strongest association with mortality: smoking (never/quit at least six months ago/current), BMI (kg/m<sup><xref ref-type="bibr" rid="c2">2</xref></sup>), depression (number of indicators 0–3), alcohol intake (grams of ethanol per week), education (expected years to complete the highest attained degree), and self-rated health (1–5). Supplementary table S2 presents more information on the measurement of the phenotypes and their distributions. For parsimony and comparability to the PGIs, these phenotypes were also standardised to SD units in the main analysis, whereas analyses of categorically measured phenotypes are presented in the supplement. After excluding individuals with any missing information, analysis that included phenotypes had 37,548 individuals and 5407 deaths. Supplementary table S3 presents correlations between PGIs and studied phenotypes.</p>
</sec>
<sec id="s2c">
<title>Modelling</title>
<p>We estimated Cox proportional hazards regressions predicting mortality by each PGI. We used age as the time scale as recommended in <sup><xref ref-type="bibr" rid="c23">23</xref></sup>. All the models were adjusted for indicators for the data collection baseline year, sex, and the ten first principal components of the full (pruned) single nucleotide polymorphism (SNP) matrix. The models were first estimated for the whole population sample. We compared these models to the corresponding within-sibship models, using the sibship identifier as the strata variable. This method employs a sibship-specific (instead of a whole-sample-wide baseline hazard in the population models) baseline hazard, and corresponds to a fixed-effects model in some other regression frameworks (e.g., linear model with sibship-specific intercepts)<sup><xref ref-type="bibr" rid="c24">24</xref>,<xref ref-type="bibr" rid="c25">25</xref></sup>.</p>
<p>Next, we assessed heterogenous associations by estimating the corresponding models among men and women separately, as well as in three education groups. We also investigated possible age-related heterogeneous patterns, fitting the corresponding model in three age-specific mortality follow-up periods (25–64 years, 65–79 years, 80+ years). We also conducted an additional analysis by separating the outcome to external and natural causes of death.</p>
<p>Finally, we analysed the six PGIs with the strongest association to mortality in more detail. Here we also measured the corresponding phenotypes and fitted four types of models: Model 1 was adjusted for controls and each PGI/phenotype separately. Model 2 jointly adjusted for corresponding PGI and phenotype. Model 3 adjusted for all PGIs or phenotypes (but not both simultaneously) and Model 4 adjusted for all six PGIs and phenotypes simultaneously. We also carried out an analysis stratified by whether the study participants did or did not have the phenotypic risk factor.</p>
<p>The proportional hazards assumption of Cox models was evaluated with Schoenfeld residuals (see Supplementary table S4)<sup><xref ref-type="bibr" rid="c26">26</xref></sup>. Residual correlations of PGIs were no more than 0.050 of their absolute value. The correlations with investigated phenotypes were higher, however, particularly for (continuous) BMI (-0.099).</p>
<p>Multiple-testing adjustments of p-values were conducted with the Benjamini–Hochberg method<sup><xref ref-type="bibr" rid="c27">27</xref></sup> for 35 multiple tests.</p>
<p>The software used for producing genetic variables was PLINK versions 1.9 and 2.0. The statistical analysis was conducted with Stata versions 16 and 18.</p>
</sec>
</sec>
<sec id="s3">
<title>Results</title>
<p><xref rid="fig1" ref-type="fig">Figure 1</xref> displays the associations between 35 PGIs and all-cause mortality for the population analysis and within-sibship analysis samples. In the population analysis, the PGIs that showed the strongest associations with mortality were ever smoking (hazard ratio [HR] per 1 SD larger PGI =1.12, 95% confidence interval [95% CI] 1.09; 1.15), self-rated health (HR=0.90, 95% CI 0.88; 0.93), BMI (HR=1.10, 95% CI 1.07; 1.13), educational attainment (HR=0.91, 95% CI 0.89; 0.94), depressive symptoms (HR=1.07, 95% CI 1.04; 1.10), and drinks per week (HR=1.06, 95% CI 1.04; 1.09). Most of the studied PGIs had negligible associations with mortality, as 18 PGIs had HRs between 0.98 and 1.02.</p>
<fig id="fig1" position="float" orientation="portrait" fig-type="figure">
<label>Figure 1</label>
<caption><title>Hazard ratios of polygenic indices for all-cause mortality. Population and within-sibship estimates</title>
<p><xref rid="fig1" ref-type="fig">Figure 1</xref> note: Estimates from Cox proportional hazards models adjusted for indicators for the baseline year, sex and 10 first principal components of the genome. Capped bars are 95% confidence intervals. For a table of corresponding estimates, see Supplementary table S5. Abbreviations: HR=Hazard ratio; ADHD=Attention deficit hyperactivity disorder.</p></caption>
<graphic xlink:href="25323952v2_fig1.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>Although CIs overlapped with regards to every individual PGI except extraversion, on average within-sibship analysis had marginally larger associations than the population analysis (inverse-variance-weighted mean absolute log HR was 0.023, 95% CI 0.005; 0.042 larger in within-sibship than population analyses). In within-sibship analysis, the PGI of BMI had the strongest association with mortality (HR=1.22, 95% CI 1.10; 1.36).</p>
<p><xref rid="fig2" ref-type="fig">Figure 2</xref> presents PGI–mortality associations by sex, education, age, and cause of death. Overall, men had slightly stronger PGI–mortality associations (Panel A; inverse-variance-weighted mean absolute log HR was 0.013, 95% CI 0.005; 0.022 larger among men). The largest sex differences were observed for the PGI for educational attainment (HR=0.89, 95% CI 0.86; 0.92 among men; HR=0.95, 95% CI 0.91; 0.99 among women; p=0.010 for difference, p=0.33 after multiple-testing adjustment with Benjamini–Hochberg method for 35 joint tests) and PGI for attention deficit hyperactivity disorder (ADHD; HR=1.08, 95% CI 1.04; 1.11 among men; HR=1.01, 95% CI 0.97; 1.05 among women; p=0.012 for difference, p=0.42 after multiple-testing adjustment). The HRs in Panel B indicate no evidence for substantial heterogeneous associations by education level. Panel C analyses mortality in three age-specific follow-up periods. The PGIs were more predictive of death in younger age groups, although the difference between the 25–64 and 65–79 age groups was small, except for the PGI of ADHD (HR=1.14, 95% CI 1.08; 1.21 for 25–64-year-olds; HR=1.04, 95% CI 1.00; 1.08 for 65–79-year-olds; p=0.008 for difference, p=0.27 after multiple-testing adjustment). PGIs predicted death only negligibly among those aged 80+, and the largest differences between the age groups 25–64 and 80+ were for PGIs of self-rated health (HR=0.87, 95% CI 0.82; 0.93 for 25–64-year-olds, HR=1.00, 95% CI 0.94; 1.04 for 80+ year-olds, p=2*10<sup>-4</sup> for difference, p=0.006 after multiple-testing adjustment), ADHD (HR=1.14, 95% CI 1.08; 1.21 for 25–64-year-olds, HR=0.99, 95% CI 0.95; 1.03 for 80+ year-olds, p=7*10<sup>-4</sup> for difference, p=0.012 after multiple-testing adjustment) and depressive symptoms (HR=1.12, 95% CI 1.06; 1.18 for 25–64-year-olds, HR=1.00, 95% CI 0.96; 1.04 for 80+ year-olds, p=0.002 for difference, p=0.032 after multiple-testing adjustment). Additionally, the difference in HRs between these age groups achieved significance after multiple-testing adjustment at the conventional 5% level for PGIs of cigarettes per day, educational attainment, and ever smoking.</p>
<fig id="fig2" position="float" orientation="portrait" fig-type="figure">
<label>Figure 2.</label>
<caption><title>Hazard ratios of polygenic indices for all-cause mortality by sex (Panel A), educational group (Panel B), age-specific mortality follow-up period (Panel C), and cause of death (Panel D)</title>
<p><xref rid="fig2" ref-type="fig">Figure 2</xref> note: Estimates from Cox proportional hazards models adjusted for indicators for the baseline year, sex and 10 first principal components of the genome. Capped bars are 95% confidence intervals. For a table of corresponding estimates, see Supplementary table S6. Abbreviations: HR=Hazard ratio; ADHD=Attention deficit hyperactivity disorder.</p></caption>
<graphic xlink:href="25323952v2_fig2.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>Panel D displays that most PGIs had stronger associations with external (accidents, suicides, violence, and alcohol-related causes of death) than natural causes of death. An exception was the PGI of BMI that had a larger HR for natural (HR=1.11, 95% CI 1.08; 1.14) than external causes of death (HR=1.01, 95% CI 0.93; 1.10). The HR differences between external and natural causes of death were nominally significant at the conventional 5% level for cannabis use (p=0.016), drinks per week (p=0.028), left out of social activity (p=0.029), ADHD (p=0.031), BMI (p=0.035) and height (p=0.049), but none of these differences remained significant after adjusting for 35 multiple tests. For external causes, the strongest associations were observed for the PGI for drinks per week (HR=1.16, 95% CI 1.07; 1.26), depressive symptoms (HR=1.15, 95% CI 1.06; 1.25), educational attainment (HR=0.88, 95% CI 0.81; 0.95) and ADHD (HR=1.14, 95% CI 1.05; 1.23). Twelve PGIs had HRs ≥1.1 (drinks per week, depressive symptoms, cigarettes per day, ADHD, alcohol misuse, ever smoking, risk tolerance) or ≤0.9 (cannabis use, self-rated health, religious attendance, age at first birth and educational attainment) per 1 SD difference in PGI, whereas only three PGIs had HRs ≥1.1 or ≤0.9 for natural causes of death (ever smoking, BMI and self-rated health). HRs of natural causes of death followed similar patterns as all-cause mortality, which was expected, as they constituted 90% of all observed deaths.</p>
<p><xref rid="tbl1" ref-type="table">Table 1</xref> shows HRs of the six most predictive PGIs (ever smoking, BMI, depressive symptoms, drinks per week, educational attainment and self-rated health) and their corresponding phenotypes (smoking, self-rated health, years of education, BMI, number of depression indicators, and alcohol intake per week) for all-cause mortality. Models 1a–1l present HRs of each variable adjusted only for baseline covariates. All phenotypes except BMI had stronger associations with mortality than their corresponding PGIs. Models 2a–2f adjust for each phenotype and its corresponding PGI simultaneously. HRs of phenotypes were only slightly attenuated, whereas for PGIs this attenuation was around one-third on average. Nevertheless, each PGI was clearly associated with mortality even after adjusting for its phenotype, and all estimated 95% CIs excluded one in Models 2a–2f. Model 3a adjusted for all six phenotypes and 3b all six PGIs simultaneously. The most substantial attenuation was observed for depression indicators and the PGI of depressive symptoms. Finally, Model 4 adjusted for all phenotypes and PGIs simultaneously. In Model 4, PGIs had modest independent associations, the strongest observed being for the PGI of smoking (HR=1.04, 95% CI 1.01; 1.08), PGI of BMI (HR=1.03, 95% CI 1.00; 1.06) and PGI of drinks per week (HR=1.03, 95% CI 1.00; 1.06). Supplementary table S7 presents corresponding analyses with categorised phenotypes, indicating curvilinear mortality patterns for BMI and alcohol intake. Although HRs of these phenotypes in <xref rid="tbl1" ref-type="table">Table 1</xref> should thus be interpreted with caution, HRs of PGIs were consistent between the analyses presented in <xref rid="tbl1" ref-type="table">Table 1</xref> and Supplementary table S7.</p>
<table-wrap id="tbl1" orientation="portrait" position="float">
<label>Table 1.</label>
<caption><title>Hazard ratios of selected polygenic indices and corresponding phenotypes for all-cause mortality (N: 37,548 individuals; 5407 deaths)</title></caption>
<graphic xlink:href="25323952v2_tbl1.tif" mimetype="image" mime-subtype="tiff"/>
</table-wrap>
<p>Supplementary table S8 presents information criteria and significance tests on corresponding models. Models with PGI+phenotype (Models 2a–f) showed improvement over models with the phenotype only (Models 1a, 1c, 1e, 1g, 1i, 1k, with a p=0.0006 or lower) in terms of both Akaike information criterion (AIC) as well as Bayesian (Schwarz) information criterion (BIC) with a p=0.0006 or lower in all comparisons. The full Model 4 again showed improvement over the model with all PGIs jointly (Model 3b, with a p=0.0002 or p=0.00002, depending on continuous/categorical phenotype measurement), which had a lower AIC but not BIC.</p>
<p><xref rid="tbl2" ref-type="table">Table 2</xref> shows the associations between these six PGIs (ever smoking, BMI, depressive symptoms, drinks per week, educational attainment and self-rated health) and all-cause mortality stratified by whether an individual was lacking the phenotype risk factor in question. We did not observe evidence for substantial difference in the PGI–mortality HRs between individuals with and without these risk factors in their corresponding phenotype. Furthermore, the only PGI that showed consistent attenuation in their HRs compared to the analysis on the whole sample (presented in <xref rid="tbl1" ref-type="table">Table 1</xref> and <xref rid="fig1" ref-type="fig">Figure 1</xref>) was the PGI of ever smoking (HR=1.07, 95% CI 1.03; 1.11 for never smokers; HR=1.09, 95% CI 1.05; 1.12 for others; HR=1.12, 95% CI 1.09; 1.15 for unstratified population analysis).</p>
<table-wrap id="tbl2" orientation="portrait" position="float">
<label>Table 2.</label>
<caption><title>Hazard ratios of selected polygenic indices for all-cause mortality regarding belonging to a risk category in the related phenotypes</title></caption>
<graphic xlink:href="25323952v2_tbl2.tif" mimetype="image" mime-subtype="tiff"/>
</table-wrap>
</sec>
<sec id="s4">
<title>Discussion</title>
<p>We investigated the association between 35 PGIs – mostly related to social, psychological, and behavioural traits, or typically non-fatal health conditions – and mortality using a population-representative register-linked sample from Finland with up to 25-year mortality follow-up. PGIs most strongly associated with mortality were typically related to the best-established phenotypic mortality risk factors, including smoking, body mass index, depression, alcohol use, education and self-rated health <sup><xref ref-type="bibr" rid="c28">28</xref>–<xref ref-type="bibr" rid="c30">30</xref></sup>. Although the majority of the investigated PGIs had negligible associations with the risk of death, the strongest associations observed were about a 10% difference in the mortality hazard for 1 SD difference in PGI. Given the severity of the outcome, these associations cannot be disregarded as trivial, particularly when considering individuals with particularly high or low PGIs. Our within-sibship analyses showed broadly similar results and thus do not indicate that these PGI–mortality associations were systematically inflated due to population stratification or related biases. Limited previous literature exists overall on PGI–mortality associations, particularly for other than disease-or biomarker-related PGIs. Nevertheless, the associations of PGIs of smoking, alcohol consumption, depression and BMI that we observed for Finland were roughly comparable or moderately stronger than what was observed in a previous study on the UK Biobank for PGIs unadjusted for each other<sup><xref ref-type="bibr" rid="c12">12</xref></sup> and in US-based Health and Retirement Study for mutually adjusted PGIs<sup><xref ref-type="bibr" rid="c11">11</xref></sup>.</p>
<p>The investigated PGIs were slightly more predictive of mortality among men than women across the board. This aligns with sex differences for all-cause mortality observed for many social-level mortality risk phenotypes such as socioeconomic position and marital status<sup><xref ref-type="bibr" rid="c31">31</xref>–<xref ref-type="bibr" rid="c33">33</xref></sup>, but similar excess risk among men is not consistently observed on more physiologically proximate or behavioural mortality risk phenotypes such as obesity, alcohol use and smoking<sup><xref ref-type="bibr" rid="c34">34</xref>–<xref ref-type="bibr" rid="c36">36</xref></sup>. We also evaluated but did not observe differences in PGI–mortality associations between education groups. The PGIs were more predictive of death at younger ages, whereas among those who survived to age 80, PGIs made hardly any difference in mortality risk. Such an age-related heterogenous pattern is consistent with a previous study analysing age–PGI associations on common diseases in the UK Biobank<sup><xref ref-type="bibr" rid="c37">37</xref></sup>. In contrast, a previous study found stronger HRs in older age groups when directly identifying SNPs associated with mortality<sup><xref ref-type="bibr" rid="c7">7</xref></sup>. A possible explanation for such an ‘age as a leveller’ pattern (see <sup><xref ref-type="bibr" rid="c14">14</xref>,<xref ref-type="bibr" rid="c38">38</xref></sup>) may lie in the increasing importance of acute mortality-risk-enhancing factors towards the end of life, including emerging and progressing illness and biological ageing, which trump more distant and indirect mechanisms<sup><xref ref-type="bibr" rid="c14">14</xref>,<xref ref-type="bibr" rid="c39">39</xref></sup>. Such age-specific heterogeneity also has methodological implications. Researchers analysing PGI–mortality associations using samples of (disproportionately) older individuals should be cautious in generalising their results to the overall population due to potential survivorship bias<sup><xref ref-type="bibr" rid="c40">40</xref>,<xref ref-type="bibr" rid="c41">41</xref></sup>.</p>
<p>In general, PGIs were more strongly predictive of external than natural causes of death, and this was particularly evident for many psychological and behavioural PGIs, including alcohol drinks per week, ADHD, depressive symptoms, religious attendance, and risk tolerance. Only the PGI of BMI showed a clearly stronger association with natural causes. It is worth noting that despite that alcohol-related deaths were included in external causes, smoking-related PGIs predicted both external and natural mortality in a roughly consistent manner and the PGI of cannabis use even had a negative association with external mortality. This suggests that despite a substantial shared genetic aetiology between different addictions<sup><xref ref-type="bibr" rid="c42">42</xref>,<xref ref-type="bibr" rid="c43">43</xref></sup>, the genetic architecture between the use of different substances also differs importantly from the perspective of mortality risk.</p>
<p>Among those PGIs that were most predictive of mortality, their associations tend to be roughly one-third of the strength of the respective phenotypes when mutually adjusted, although with substantial variation between phenotypes. Additionally, PGIs were also predictive among those who lack the phenotypic risk factor. These two observations imply that PGIs provide additional information on the risk of death even when the phenotypic measures are available. The potential advantage of PGIs in research and healthcare relative to phenotype is that they need to be measured only once, whereas for many phenotypes the most precise monitoring would require extensive longitudinal measures. This is particularly relevant for phenotypes related to specific points of the life course, e.g., on health-related factors typically manifesting at older age. This suggests that the independent association of PGIs might be stronger if we had even longer mortality follow-up. Additionally, PGIs capture liabilities on a continuum, which may offer an advantage in risk assessment compared to phenotypes that are typically measured through binary diagnoses or with limited categories. PGIs also avoid some potential forms of measurement error, such as those related to self-reporting or short-term variations over time.</p>
<p>The strengths of this study included population-representative data with high response rates linked to a long register-based follow-up with minimal attrition-related biases. On the other hand, PGIs have known limitations since they incompletely capture the genetic liability, are agnostic regarding the specific biological mechanisms and may also capture environmental signals<sup><xref ref-type="bibr" rid="c1">1</xref></sup>. Within-sibship analysis allowed us to evaluate and mitigate population stratification and other related biases in the analyses, however, at the cost of power and increased sensitivity to measurement error<sup><xref ref-type="bibr" rid="c44">44</xref></sup>. Overall, these analyses confirmed our main findings. In addition, comparability of the PGIs may be affected by differences in the GWASes that underlie them, e.g., in their sample sizes and phenotype measurement quality. Finally, despite the Schoenfeld residual correlations suggesting some violation of the proportional hazards assumption, such correlations were present for phenotypes (instead of PGIs) that were not of the primary interest in the analysis.</p>
<p>To conclude, PGIs related to the best-established phenotypic risk factors had the strongest associations with mortality. Particularly for deaths occurring at a younger age, PGIs confer additional information on mortality risk, even when information on the related phenotype is available, and within-sibship analysis suggests that such associations do not appear to be systematically inflated due to population phenomena.</p>
</sec>

</body>
<back>
<sec id="s7" sec-type="data-availability">
<title>Data availability</title>
<p>Due to data protection regulations of the biobank and national register-holders providing the data, data are confidential and we are not allowed to make the individual-level data available to third parties. Datasets are available from the THL Biobank on written application and following the instructions given on the website of the Biobank (<ext-link ext-link-type="uri" xlink:href="https://thl.fi/en/research-and-development/thl-biobank/for-researchers">https://thl.fi/en/research-and-development/thl-biobank/for-researchers</ext-link>, contact admin.biobank (at) thl.fi). Register linkage from these data may be applied for from Findata (<ext-link ext-link-type="uri" xlink:href="https://findata.fi/en/permits/">https://findata.fi/en/permits/</ext-link>). The use of those PGIs that include samples from 23andme data collections require their own permission to use by the 23andMe, Inc (apply.research (at) <ext-link ext-link-type="uri" xlink:href="https://23andme.com">https://23andme.com</ext-link>).</p>
</sec>
<ack>
<title>Acknowledgements</title>
<p>We thank Aysu Okbay for the weighting of the PGIs used. We would like to thank the research participants and employees of 23andMe, Inc. for making this work possible. The genetic samples used for the research were obtained from the THL Biobank (study number: THLBB2020_8/ THLBB2023_51), and we thank all study participants for their generous participation in the THL Biobank.</p>
</ack>
<sec id="additional-info" sec-type="additional-information">
<title>Additional information</title>
<sec id="s6" sec-type="ethics-statement">
<title>Ethics approval</title>
<p>The Finnish Social and Health Data Permit Authority (Findata) has accepted the use of clinical data (THL/4725/14.02.00/2020; THL/1423/14.06.00/2022), and the THL Biobank has approved the use of genetic data (THLBB2020_8; THLBB2023_51) and the data linkage to the Finnish population registers (TK-53-876-20; TK/2041/07.03.00/2023). All participants gave their informed consent.</p>
</sec>
<sec id="s8">
<title>Author contributions</title>
<p>HL conceptualised the study, contributed the data preparation, conducted the main analysis and wrote the first draft. AG, KK and PM contributed to the data infrastructure and data preparation for analysis. JK, KK and SL supported the empirical analysis with their methodological expertise. AG, JK, KK, SL, KS and PM revised the manuscript text with critical content and contributed to the interpretation of the findings.</p>
</sec>
<sec id="s9">
<title>Funding</title>
<p>HL was supported by the European Research Council [grant #101019329] as well as the Max Planck – University of Helsinki Center for Social Inequalities in Population Health. SL gratefully acknowledges funding from the Research Council of Finland (# 350399).</p>
<p>PM was supported by the European Research Council under the European Union’s Horizon 2020 research and innovation programme (#101019329), the Strategic Research Council (SRC) within the Research Council of Finland grants for ACElife (#352543-352572) and LIFECON (#345219), the Research Council of Finland profiling grant for SWAN (#136528219) and FooDrug (# 136528212), and grants to the Max Planck – University of Helsinki Centre for Social Inequalities in Population Health from the Jane and Aatos Erkko Foundation (#210046), the Max Planck Society (# 5714240218), University of Helsinki (#77204227), and Cities of Helsinki, Vantaa and Espoo (#4706914). The study does not necessarily reflect the Commission’s views and in no way anticipates the Commission’s future policy in this area. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.</p>
</sec>
</sec>
<sec id="additional-files" sec-type="supplementary-material">
<title>Additional files</title>
<supplementary-material id="supp1">
<label>Supplementary table</label>
<media xlink:href="supplements/323952_file02.xlsx"/>
</supplementary-material>
</sec>
<ref-list>
<title>References</title>
<ref id="c1"><label>1.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Burt</surname> <given-names>CH</given-names></string-name></person-group>. <article-title>Polygenic Indices (aka Polygenic Scores) in Social Science: A Guide for Interpretation and Evaluation</article-title>. <source>Sociol Methodol</source>. <year>2024</year> Aug;<volume>54</volume>(<issue>2</issue>):<fpage>300</fpage>–<lpage>350</lpage>.</mixed-citation></ref>
<ref id="c2"><label>2.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Becker</surname> <given-names>J</given-names></string-name>, <string-name><surname>Burik</surname> <given-names>CAP</given-names></string-name>, <string-name><surname>Goldman</surname> <given-names>G</given-names></string-name>, <etal>et al.</etal></person-group> <article-title>Resource profile and user guide of the Polygenic Index Repository</article-title>. <source>Nat Hum Behav</source>. <year>2021</year> Dec;<volume>5</volume>(<issue>12</issue>):<fpage>1744</fpage>–<lpage>1758</lpage>.</mixed-citation></ref>
<ref id="c3"><label>3.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Choi</surname> <given-names>SW</given-names></string-name>, <string-name><surname>Mak</surname> <given-names>TS-H</given-names></string-name>, <string-name><surname>O’Reilly</surname> <given-names>PF.</given-names></string-name></person-group> <article-title>Tutorial: a guide to performing polygenic risk score analyses</article-title>. <source>Nat Protoc</source>. <year>2020</year>; <volume>15</volume>(<issue>9</issue>):<fpage>2759</fpage>–<lpage>2772</lpage>.</mixed-citation></ref>
<ref id="c4"><label>4.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Torkamani</surname> <given-names>A</given-names></string-name>, <string-name><surname>Wineinger</surname> <given-names>NE</given-names></string-name>, <string-name><surname>Topol</surname> <given-names>EJ.</given-names></string-name></person-group> <article-title>The personal and clinical utility of polygenic risk scores</article-title>. <source>Nat Rev Genet</source>. <year>2018</year> Sep; <volume>19</volume>(<issue>9</issue>):<fpage>581</fpage>–<lpage>590</lpage>.</mixed-citation></ref>
<ref id="c5"><label>5.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lambert</surname> <given-names>SA</given-names></string-name>, <string-name><surname>Abraham</surname> <given-names>G</given-names></string-name>, <string-name><surname>Inouye</surname> <given-names>M</given-names></string-name></person-group>. <article-title>Towards clinical utility of polygenic risk scores</article-title>. <source>Hum Mol Genet</source>. <year>2019</year> Nov 21;<volume>28</volume>(<issue>R2</issue>):<fpage>R133</fpage>–<lpage>R142</lpage>.</mixed-citation></ref>
<ref id="c6"><label>6.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lewis</surname> <given-names>CM</given-names></string-name>, <string-name><surname>Vassos</surname> <given-names>E</given-names></string-name></person-group>. <article-title>Polygenic risk scores: from research tools to clinical instruments</article-title>. <source>Genome Med</source>. <year>2020</year> May 18; <volume>12</volume>(<issue>1</issue>):<fpage>44</fpage>.</mixed-citation></ref>
<ref id="c7"><label>7.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ganna</surname> <given-names>A</given-names></string-name>, <string-name><surname>Rivadeneira</surname> <given-names>F</given-names></string-name>, <string-name><surname>Hofman</surname> <given-names>A</given-names></string-name>, <etal>et al.</etal></person-group> <article-title>Genetic determinants of mortality. Can findings from genome-wide association studies explain variation in human mortality?</article-title> <source>Hum Genet</source>. <year>2013</year> May; <volume>132</volume>(<issue>5</issue>):<fpage>553</fpage>–<lpage>561</lpage>.</mixed-citation></ref>
<ref id="c8"><label>8.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Jukarainen</surname> <given-names>S</given-names></string-name>, <string-name><surname>Kiiskinen</surname> <given-names>T</given-names></string-name>, <string-name><surname>Kuitunen</surname> <given-names>S</given-names></string-name>, <etal>et al.</etal></person-group> <article-title>Genetic risk factors have a substantial impact on healthy life years</article-title>. <source>Nat Med</source>. <year>2022</year> Sep;<volume>28</volume>(<issue>9</issue>):<fpage>1893</fpage>–<lpage>1901</lpage>.</mixed-citation></ref>
<ref id="c9"><label>9.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sakaue</surname> <given-names>S</given-names></string-name>, <string-name><surname>Kanai</surname> <given-names>M</given-names></string-name>, <string-name><surname>Karjalainen</surname> <given-names>J</given-names></string-name>, <etal>et al.</etal></person-group> <article-title>Trans-biobank analysis with 676,000 individuals elucidates the association of polygenic risk scores of complex traits with human lifespan</article-title>. <source>Nat Med</source>. <year>2020</year> Apr;<volume>26</volume>(<issue>4</issue>):<fpage>542</fpage>–<lpage>548</lpage>.</mixed-citation></ref>
<ref id="c10"><label>10.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Argentieri</surname> <given-names>MA</given-names></string-name>, <string-name><surname>Amin</surname> <given-names>N</given-names></string-name>, <string-name><surname>Nevado-Holgado</surname> <given-names>AJ</given-names></string-name>, <etal>et al.</etal></person-group> <article-title>Integrating the environmental and genetic architectures of aging and mortality</article-title>. <source>Nat Med. Nature Publishing Group</source>; <year>2025</year> Mar;<volume>31</volume>(<issue>3</issue>):<fpage>1016</fpage>–<lpage>1025</lpage>.</mixed-citation></ref>
<ref id="c11"><label>11.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Karlsson Linnér</surname> <given-names>R</given-names></string-name>, <string-name><surname>Koellinger</surname> <given-names>PD</given-names></string-name></person-group>. <article-title>Genetic risk scores in life insurance underwriting</article-title>. <source>J Health Econ</source>. <year>2022</year> Jan 1;<volume>81</volume>:<issue>102556</issue>.</mixed-citation></ref>
<ref id="c12"><label>12.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Meisner</surname> <given-names>A</given-names></string-name>, <string-name><surname>Kundu</surname> <given-names>P</given-names></string-name>, <string-name><surname>Zhang</surname> <given-names>YD</given-names></string-name>, <etal>et al.</etal></person-group> <article-title>Combined utility of 25 disease and risk factor polygenic risk scores for stratifying risk of all-cause mortality</article-title>. <source>Am J Hum Genet</source>; <year>2020</year>; <volume>107</volume>(<issue>3</issue>):<fpage>418</fpage>–<lpage>431</lpage>.</mixed-citation></ref>
<ref id="c13"><label>13.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Howe</surname> <given-names>LJ</given-names></string-name>, <string-name><surname>Nivard</surname> <given-names>MG</given-names></string-name>, <string-name><surname>Morris</surname> <given-names>TT</given-names></string-name>, <etal>et al.</etal></person-group> <article-title>Within-sibship genome-wide association analyses decrease bias in estimates of direct genetic effects</article-title>. <source>Nat Genet</source>. <year>2022</year> May 1;<volume>54</volume>(<issue>5</issue>):<fpage>581</fpage>–<lpage>592</lpage>.</mixed-citation></ref>
<ref id="c14"><label>14.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hoffmann</surname> <given-names>R</given-names></string-name>, <string-name><surname>Kröger</surname> <given-names>H</given-names></string-name>, <string-name><surname>Tarkiainen</surname> <given-names>L</given-names></string-name>, <string-name><surname>Martikainen</surname> <given-names>P</given-names></string-name></person-group>. <article-title>Dimensions of Social Stratification and Their Relation to Mortality: A Comparison Across Gender and Life Course Periods in Finland</article-title>. <source>Soc Indic Res</source>. <year>2019</year> Aug 1; <volume>145</volume>(<issue>1</issue>):<fpage>349</fpage>–<lpage>365</lpage>.</mixed-citation></ref>
<ref id="c15"><label>15.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Rogers</surname> <given-names>RG</given-names></string-name>, <string-name><surname>Everett</surname> <given-names>BG</given-names></string-name>, <string-name><surname>Onge</surname> <given-names>JMS</given-names></string-name>, <string-name><surname>Krueger</surname> <given-names>PM</given-names></string-name></person-group>. <article-title>Social, behavioral, and biological factors, and sex differences in mortality</article-title>. <source>Demography</source>. <year>2010</year> Aug 1;<volume>47</volume>(<issue>3</issue>):<fpage>555</fpage>–<lpage>578</lpage>.</mixed-citation></ref>
<ref id="c16"><label>16.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Borodulin</surname> <given-names>K</given-names></string-name>, <string-name><surname>Tolonen</surname> <given-names>H</given-names></string-name>, <string-name><surname>Jousilahti</surname> <given-names>P</given-names></string-name>, <etal>et al.</etal></person-group> <article-title>Cohort profile: the National FINRISK study</article-title>. <source>Int J Epidemiol</source>. <year>2018</year>;<volume>47</volume>(<issue>3</issue>):<fpage>696</fpage>–<lpage>696i</lpage>.</mixed-citation></ref>
<ref id="c17"><label>17.</label><mixed-citation publication-type="book"><person-group person-group-type="author"><string-name><surname>Borodulin</surname> <given-names>K</given-names></string-name>, <string-name><surname>Sääksjärvi</surname> <given-names>K.</given-names></string-name></person-group> <source>FinHealth 2017 Study: Methods</source>. <publisher-name>Helsinki</publisher-name>: <publisher-loc>THL</publisher-loc>; <year>2019</year>. Report No.: 17/2019.</mixed-citation></ref>
<ref id="c18"><label>18.</label><mixed-citation publication-type="report"><person-group person-group-type="author"><string-name><surname>Lundqvist</surname> <given-names>A</given-names></string-name>, <string-name><surname>Mäki-Opas</surname> <given-names>T.</given-names></string-name></person-group> <source>Health 2011 Survey - Methods</source>. <publisher-loc>Tampere</publisher-loc>: <publisher-name>Juvenes Print</publisher-name>; <year>2016</year> [cited 2021 Nov 30]. Available from: <ext-link ext-link-type="uri" xlink:href="https://www.julkari.fi/handle/10024/130780">https://www.julkari.fi/handle/10024/130780</ext-link></mixed-citation></ref>
<ref id="c19"><label>19.</label><mixed-citation publication-type="other"><person-group person-group-type="author"><string-name><surname>Pärn</surname> <given-names>K</given-names></string-name>, <string-name><surname>Fontarnau</surname> <given-names>JN</given-names></string-name>, <string-name><surname>Isokallio</surname> <given-names>MA</given-names></string-name>, <etal>et al.</etal></person-group> <article-title>Genotyping chip data lift-over to reference genome build GRCh38/hg38</article-title>. <source>Protocols.io</source>; <year>2018</year>. <pub-id pub-id-type="doi">10.17504/protocols.io.nqtddwn</pub-id></mixed-citation></ref>
    <ref id="c20"><label>20.</label><mixed-citation publication-type="other"><person-group person-group-type="author"><string-name><surname>Pärn</surname> <given-names>K</given-names></string-name>, <string-name><surname>Isokallio</surname> <given-names>MA</given-names></string-name>, <string-name><surname>Nunez-Fontarnau</surname> <given-names>J</given-names></string-name>, <string-name><surname>Palotie</surname> <given-names>A</given-names></string-name>, <string-name><surname>Ripatti</surname> <given-names>S</given-names></string-name>, <string-name><surname>Palta</surname> <given-names>P</given-names></string-name></person-group>. <article-title>Genotype imputation workflow v3.0</article-title>. <source>Protocols.io</source>. <year>2018</year>. <pub-id pub-id-type="doi">10.17504/protocols.io.nmndc5e</pub-id></mixed-citation></ref>
<ref id="c21"><label>21.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kaprio</surname> <given-names>J.</given-names></string-name></person-group> <article-title>The Finnish twin cohort study: an update</article-title>. <source>Twin Res Hum Genet</source>. <year>2013</year>; <volume>16</volume>(<issue>1</issue>):<fpage>157</fpage>–<lpage>162</lpage>.</mixed-citation></ref>
<ref id="c22"><label>22.</label><mixed-citation publication-type="web"><article-title>PGI Repository</article-title>. <source>SSGAC</source> [cited <year>2025</year> Feb 19]. Available from: <ext-link ext-link-type="uri" xlink:href="https://www.thessgac.org/pgi-repository">https://www.thessgac.org/pgi-repository</ext-link></mixed-citation></ref>
<ref id="c23"><label>23.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Thiébaut</surname> <given-names>ACM</given-names></string-name>, <string-name><surname>Bénichou</surname> <given-names>J</given-names></string-name></person-group>. <article-title>Choice of time-scale in Cox’s model analysis of epidemiologic cohort data: a simulation study</article-title>. <source>Stat Med</source>. <year>2004</year> Dec 30;<volume>23</volume>(<issue>24</issue>):<fpage>3803</fpage>–<lpage>3820</lpage>.</mixed-citation></ref>
<ref id="c24"><label>24.</label><mixed-citation publication-type="book"><person-group person-group-type="author"><string-name><surname>Allison</surname> <given-names>PD</given-names></string-name></person-group>. <source>Fixed effects regression models</source>. <publisher-loc>Thousand Oaks</publisher-loc>: <publisher-name>Sage</publisher-name>; <year>2009</year>.</mixed-citation></ref>
<ref id="c25"><label>25.</label><mixed-citation publication-type="book"><person-group person-group-type="author"><string-name><surname>Rabe-Hesketh</surname> <given-names>S</given-names></string-name>, <string-name><surname>Skrondal</surname> <given-names>A</given-names></string-name></person-group>. <source>Multilevel and longitudinal modeling using Stata. Volume II: categorical responses, counts, and survival</source>. <edition>Third</edition> edition. <publisher-loc>College Station</publisher-loc>: <publisher-name>Stata Press</publisher-name>; <year>2012</year>.</mixed-citation></ref>
<ref id="c26"><label>26.</label><mixed-citation publication-type="book"><person-group person-group-type="author"><string-name><surname>Allison</surname> <given-names>PD</given-names></string-name></person-group>. <source>Event history and survival analysis: Regression for longitudinal event data</source>. <edition>Second</edition> edition. <publisher-loc>Thousand Oaks</publisher-loc>: <publisher-name>SAGE</publisher-name>; <year>2014</year>.</mixed-citation></ref>
<ref id="c27"><label>27.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Benjamini</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Hochberg</surname> <given-names>Y</given-names></string-name></person-group>. <article-title>Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing</article-title>. <source>J R Stat Soc Ser B Methodol</source>. <year>1995</year>;<volume>57</volume>(<issue>1</issue>):<fpage>289</fpage>–<lpage>300</lpage>.</mixed-citation></ref>
<ref id="c28"><label>28.</label><mixed-citation publication-type="book"><person-group person-group-type="author"><string-name><surname>Hummer</surname> <given-names>RA</given-names></string-name>, <string-name><surname>Lariscy</surname> <given-names>JT.</given-names></string-name></person-group> <chapter-title>Educational Attainment and Adult Mortality</chapter-title>. In: <person-group person-group-type="editor"><string-name><surname>Rogers</surname> <given-names>RG</given-names></string-name>, <string-name><surname>Crimmins</surname> <given-names>EM</given-names></string-name></person-group>, editors. <source>Int Handb Adult Mortal</source>. <publisher-loc>Dordrecht</publisher-loc>: <publisher-name>Springer Netherlands</publisher-name>; <year>2011</year>. p. <fpage>241</fpage>–<lpage>261</lpage>.</mixed-citation></ref>
<ref id="c29"><label>29.</label><mixed-citation publication-type="book"><person-group person-group-type="author"><string-name><surname>Himes</surname> <given-names>CL.</given-names></string-name></person-group> <chapter-title>Relationships Among Health Behaviors, Health, and Mortality</chapter-title>. In: <person-group person-group-type="editor"><string-name><surname>Rogers</surname> <given-names>RG</given-names></string-name>, <string-name><surname>Crimmins</surname> <given-names>EM</given-names></string-name></person-group>, editors. <source>Int Handb Adult Mortal</source>. <publisher-loc>Dordrecht</publisher-loc>: <publisher-name>Springer</publisher-name>; <year>2011</year>. p. <fpage>289</fpage>–<lpage>310</lpage>.</mixed-citation></ref>
<ref id="c30"><label>30.</label><mixed-citation publication-type="book"><person-group person-group-type="author"><string-name><surname>Jylhä</surname> <given-names>M.</given-names></string-name></person-group> <chapter-title>Self-Rated Health and Subjective Survival Probabilities as Predictors of Mortality</chapter-title>. In: <person-group person-group-type="editor"><string-name><surname>Rogers</surname> <given-names>RG</given-names></string-name>, <string-name><surname>Crimmins</surname> <given-names>EM</given-names></string-name></person-group>, editors. <source>Int Handb Adult Mortal</source>. <publisher-loc>Dordrecht</publisher-loc>: <publisher-name>Springer</publisher-name>; <year>2011</year>. p. <fpage>329</fpage>–<lpage>344</lpage>.</mixed-citation></ref>
<ref id="c31"><label>31.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Case</surname> <given-names>A</given-names></string-name>, <string-name><surname>Paxson</surname> <given-names>CH</given-names></string-name></person-group>. <article-title>Sex differences in morbidity and mortality</article-title>. <source>Demography</source>; <year>2005</year>;<volume>42</volume>(<issue>2</issue>):<fpage>189</fpage>–<lpage>214</lpage>.</mixed-citation></ref>
<ref id="c32"><label>32.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Koskinen</surname> <given-names>S</given-names></string-name>, <string-name><surname>Martelin</surname> <given-names>T</given-names></string-name></person-group>. <article-title>Why are socioeconomic mortality differences smaller among women than among men?</article-title> <source>Soc Sci Med</source>; <year>1994</year>;<volume>38</volume>(<issue>10</issue>):<fpage>1385</fpage>–<lpage>1396</lpage>.</mixed-citation></ref>
<ref id="c33"><label>33.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wang</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Jiao</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Nie</surname> <given-names>J</given-names></string-name>, <etal>et al.</etal></person-group> <article-title>Sex differences in the association between marital status and the risk of cardiovascular, cancer, and all-cause mortality: a systematic review and meta-analysis of 7,881,040 individuals</article-title>. <source>Glob Health Res Policy</source>. <year>2020</year> Dec;<volume>5</volume>(<issue>1</issue>):<fpage>4</fpage>.</mixed-citation></ref>
<ref id="c34"><label>34.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gellert</surname> <given-names>C</given-names></string-name>, <string-name><surname>Schöttker</surname> <given-names>B</given-names></string-name>, <string-name><surname>Brenner</surname> <given-names>H</given-names></string-name></person-group>. <article-title>Smoking and All-Cause Mortality in Older People: Systematic Review and Meta-analysis</article-title>. <source>Arch Intern Med</source>. <year>2012</year> Jun 11; <volume>172</volume>(<issue>11</issue>):<fpage>837</fpage>–<lpage>844</lpage>.</mixed-citation></ref>
<ref id="c35"><label>35.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Griswold</surname> <given-names>MG</given-names></string-name>, <string-name><surname>Fullman</surname> <given-names>N</given-names></string-name>, <string-name><surname>Hawley</surname> <given-names>C</given-names></string-name>, <etal>et al.</etal></person-group> <article-title>Alcohol use and burden for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016</article-title>. <source>The Lancet</source>. <year>2018</year> Sep 22;<volume>392</volume>(<issue>10152</issue>):<fpage>1015</fpage>–<lpage>1035</lpage>.</mixed-citation></ref>
<ref id="c36"><label>36.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hu</surname> <given-names>G</given-names></string-name>, <string-name><surname>Tuomilehto</surname> <given-names>J</given-names></string-name>, <string-name><surname>Silventoinen</surname> <given-names>K</given-names></string-name>, <string-name><surname>Barengo</surname> <given-names>NC</given-names></string-name>, <string-name><surname>Peltonen</surname> <given-names>M</given-names></string-name>, <string-name><surname>Jousilahti</surname> <given-names>P.</given-names></string-name></person-group> <article-title>The effects of physical activity and body mass index on cardiovascular, cancer and all-cause mortality among 47 212 middle-aged Finnish men and women</article-title>. <source>Int J Obes</source>. <year>2005</year> Aug;<volume>29</volume>(<issue>8</issue>):<fpage>894</fpage>–<lpage>902</lpage>.</mixed-citation></ref>
<ref id="c37"><label>37.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Jiang</surname> <given-names>X</given-names></string-name>, <string-name><surname>Holmes</surname> <given-names>C</given-names></string-name>, <string-name><surname>McVean</surname> <given-names>G</given-names></string-name></person-group>. <article-title>The impact of age on genetic risk for common diseases</article-title>. <source>PLOS Genet</source>; <year>2021</year> Aug 26; <volume>17</volume>(<issue>8</issue>):<fpage>e1009723</fpage>.</mixed-citation></ref>
<ref id="c38"><label>38.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hu</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Leinonen</surname> <given-names>T</given-names></string-name>, <string-name><surname>Myrskylä</surname> <given-names>M</given-names></string-name>, <string-name><surname>Martikainen</surname> <given-names>P.</given-names></string-name></person-group> <article-title>Changes in socioeconomic differences in hospital days with age: cumulative disadvantage, age-as-leveler, or both?</article-title> <source>J Gerontol Ser B</source>. <year>2020</year>;<volume>75</volume>(<issue>6</issue>):<fpage>1336</fpage>–<lpage>1347</lpage>.</mixed-citation></ref>
<ref id="c39"><label>39.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hoffmann</surname> <given-names>R</given-names></string-name></person-group>. <article-title>Illness, not age, is the leveler of social mortality differences in old age</article-title>. <source>J Gerontol B Psychol Sci Soc Sci</source>. <year>2011</year> May;<volume>66</volume>(<issue>3</issue>):<fpage>374</fpage>–<lpage>379</lpage>.</mixed-citation></ref>
<ref id="c40"><label>40.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Digitale</surname> <given-names>JC</given-names></string-name>, <string-name><surname>Martin</surname> <given-names>JN</given-names></string-name>, <string-name><surname>Glidden</surname> <given-names>DV</given-names></string-name>, <string-name><surname>Glymour</surname> <given-names>MM</given-names></string-name></person-group>. <article-title>Key concepts in clinical epidemiology: collider-conditioning bias</article-title>. <source>J Clin Epidemiol</source>; <year>2023</year>; <volume>161</volume>:<fpage>152</fpage>–<lpage>156</lpage>.</mixed-citation></ref>
<ref id="c41"><label>41.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Akimova</surname> <given-names>ET</given-names></string-name>, <string-name><surname>Breen</surname> <given-names>R</given-names></string-name>, <string-name><surname>Brazel</surname> <given-names>DM</given-names></string-name>, <string-name><surname>Mills</surname> <given-names>MC.</given-names></string-name></person-group> <article-title>Gene-environment dependencies lead to collider bias in models with polygenic scores</article-title>. <source>Sci Rep</source>. <year>2021</year>; <volume>11</volume>(<issue>1</issue>):<fpage>1</fpage>–<lpage>9</lpage>.</mixed-citation></ref>
<ref id="c42"><label>42.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Liu</surname> <given-names>M</given-names></string-name>, <string-name><surname>Jiang</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Wedow</surname> <given-names>R</given-names></string-name>, <etal>et al.</etal></person-group> <article-title>Association studies of up to 1.2 million individuals yield new insights into the genetic etiology of tobacco and alcohol use</article-title>. <source>Nat Genet</source>. <year>2019</year>;<volume>51</volume>(<issue>2</issue>):<fpage>237</fpage>–<lpage>244</lpage>.</mixed-citation></ref>
<ref id="c43"><label>43.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Prom-Wormley</surname> <given-names>EC</given-names></string-name>, <string-name><surname>Ebejer</surname> <given-names>J</given-names></string-name>, <string-name><surname>Dick</surname> <given-names>DM</given-names></string-name>, <string-name><surname>Bowers</surname> <given-names>MS</given-names></string-name></person-group>. <article-title>The genetic epidemiology of substance use disorder: A review</article-title>. <source>Drug Alcohol Depend</source>; <year>2017</year>; <volume>180</volume>:<fpage>241</fpage>–<lpage>259</lpage>.</mixed-citation></ref>
<ref id="c44"><label>44.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gustavson</surname> <given-names>K</given-names></string-name>, <string-name><surname>Torvik</surname> <given-names>FA</given-names></string-name>, <string-name><surname>Davey Smith</surname> <given-names>G</given-names></string-name>, <string-name><surname>Røysamb</surname> <given-names>E</given-names></string-name>, <string-name><surname>Eilertsen</surname> <given-names>EM</given-names></string-name></person-group>. <article-title>Familial confounding or measurement error? How to interpret findings from sibling and co-twin control studies</article-title>. <source>Eur J Epidemiol</source>. <year>2024</year> Jun;<volume>39</volume>(<issue>6</issue>):<fpage>587</fpage>–<lpage>603</lpage>.</mixed-citation></ref>
</ref-list>
</back>
<sub-article id="sa0" article-type="editor-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.107496.2.sa3</article-id>
<title-group>
<article-title>eLife Assessment</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Franco</surname>
<given-names>Eduardo L</given-names>
</name>
<role specific-use="editor">Reviewing Editor</role>
<aff>
<institution-wrap>
<institution-id institution-id-type="ror">https://ror.org/01pxwe438</institution-id><institution>McGill University</institution>
</institution-wrap>
<city>Montreal</city>
<country>Canada</country>
</aff>
</contrib>
</contrib-group>
<kwd-group kwd-group-type="evidence-strength">
<kwd>Convincing</kwd>
</kwd-group>
<kwd-group kwd-group-type="claim-importance">
<kwd>Important</kwd>
</kwd-group>
</front-stub>
<body>
<p>This <bold>important</bold> study reports <bold>convincing</bold> evidence of associations between 35 polygenic indices (PGIs) for social, behavioural, and psychological traits, as well as other health conditions (e.g., BMI) and all-cause mortality, based on data from Finnish population-based surveys and a twin cohort linked to administrative registers. PGIs for education, depression, alcohol use, smoking, BMI, and self-rated health showed the strongest associations with all-cause mortality, in the order of ~10% increment in risk per PGI standard deviation. Effect sizes from twin-difference analyses tended to be slightly larger than those from population cohorts, a pattern opposite that generally observed when testing PGI associations with their target phenotypes, and supporting the robustness of findings to confounding by population stratification.</p>
</body>
</sub-article>
<sub-article id="sa1" article-type="referee-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.107496.2.sa2</article-id>
<title-group>
<article-title>Reviewer #1 (Public review):</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<anonymous/>
<role specific-use="referee">Reviewer</role>
</contrib>
</contrib-group>
</front-stub>
<body>
<p>Lahtinen et al. evaluated the association between polygenic scores and mortality. This question has been intensely studied (Sakaue 2020 Nature Medicine, Jukarainen 2022 Nature Medicine, Argentieri 2025 Nature Medicine), where most studies use PRS as an instrument to attribute death to different causes. The presented study focuses on polygenic scores of non-fatal outcomes and separates the cause of death into &quot;external&quot; and &quot;internal&quot;. The majority of the results are descriptive, and the data doesn't have the power to distinguish effect sizes of the interesting comparisons: (1) differences between external vs. internal (2) differences between PGI effect and measured phenotype.</p>
<p>Comments on revised version:</p>
<p>The authors answered my concerns well. I don't have any further comments.</p>
</body>
</sub-article>
<sub-article id="sa2" article-type="referee-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.107496.2.sa1</article-id>
<title-group>
<article-title>Reviewer #2 (Public review):</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<anonymous/>
<role specific-use="referee">Reviewer</role>
</contrib>
</contrib-group>
</front-stub>
<body>
<p>Summary:</p>
<p>This study provides a comprehensive evaluation of the association between polygenic indices (PGIs) for 35 lifestyle and behavioral traits and all-cause mortality, using data from Finnish population- and family-based cohorts. The analysis was stratified by sex, cause of death (natural vs. external), age at death, and participants' educational attainment. Additional analyses focused on the six most predictive PGIs, examining their independent associations after mutual adjustment and adjustment for corresponding directly measured baseline risk factors.</p>
<p>Strengths:</p>
<p>Large sample size with long-term follow-up.</p>
<p>Use of both population- and family-based analytical approaches to evaluate associations.</p>
<p>Comments on revised version:</p>
<p>I am happy with the revision. No further comments.</p>
</body>
</sub-article>
<sub-article id="sa3" article-type="author-comment">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.107496.2.sa0</article-id>
<title-group>
<article-title>Author response:</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Lahtinen</surname>
<given-names>Hannu</given-names>
</name>
<role specific-use="author">Author</role>
<contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0910-823X</contrib-id></contrib>
<contrib contrib-type="author">
<name>
<surname>Kaprio</surname>
<given-names>Jaakko</given-names>
</name>
<role specific-use="author">Author</role>
<contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3716-2455</contrib-id></contrib>
<contrib contrib-type="author">
<name>
<surname>Ganna</surname>
<given-names>Andrea</given-names>
</name>
<role specific-use="author">Author</role>
<contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8147-240X</contrib-id></contrib>
<contrib contrib-type="author">
<name>
<surname>Korhonen</surname>
<given-names>Kaarina</given-names>
</name>
<role specific-use="author">Author</role>
<contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8499-2008</contrib-id></contrib>
<contrib contrib-type="author">
<name>
<surname>Lombardi</surname>
<given-names>Stefano</given-names>
</name>
<role specific-use="author">Author</role>
<contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9100-9331</contrib-id></contrib>
<contrib contrib-type="author">
<name>
<surname>Silventoinen</surname>
<given-names>Karri</given-names>
</name>
<role specific-use="author">Author</role>
<contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1759-3079</contrib-id></contrib>
<contrib contrib-type="author">
<name>
<surname>Martikainen</surname>
<given-names>Pekka</given-names>
</name>
<role specific-use="author">Author</role>
<contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9374-1438</contrib-id></contrib>
</contrib-group>
</front-stub>
<body>
<p>The following is the authors’ response to the original reviews.</p>
<disp-quote content-type="editor-comment">
<p><bold>Public Reviews:</bold></p>
<p><bold>Reviewer #1 (Public review):</bold></p>
<p>Lahtinen et al. evaluated the association between polygenic scores and mortality. This question has been intensely studied (Sakaue 2020 Nature Medicine, Jukarainen 2022 Nature Medicine, Argentieri 2025 Nature Medicine), where most studies use PRS as an instrument to attribute death to different causes. The presented study focuses on polygenic scores of non-fatal outcomes and separates the cause of death into &quot;external&quot; and &quot;internal&quot;. The majority of the results are descriptive, and the data doesn't have the power to distinguish effect sizes of the interesting comparisons: (1) differences between external vs. internal (2) differences between PGI effect and measured phenotype. I have two main comments:</p>
<p>(1) The authors should clarify whether the p-value reported in the text will remain significant after multiple testing adjustment. Some of the large effects might be significant; for example, Figure 2C</p>
</disp-quote>
<p>We have now added Benjamini-Hochberg multiple-testing adjusted p-values in the text each time we present nominal p-values. Additionally, supplementary tables S5 and S6 provide multiple-adjusted p-values for all analysed PGIs.</p>
<p>Although this was not always the case, many comparisons remained significant after multiple testing adjustments, especially in Figure 2C that the reviewer commented on. In the revised version, we have placed more emphasis on describing these HRs that have low p-values after multiple-test adjustment. The revised text for Figure 2C in the Results section now reads:</p>
<p>Panel C analyses mortality in three age-specific follow-up periods. The PGIs were more predictive of death in younger age groups, although the difference between the 25–64 and 65–79 age groups was small, except for the PGI of ADHD (HR=1.14, 95% CI 1.08; 1.21 for 25–64-year-olds; HR=1.04, 95% CI 1.00; 1.08 for 65–79-year-olds; p=0.008 for difference, p=0.27 after multiple-testing adjustment). PGIs predicted death only negligibly among those aged 80+, and the largest differences between the age groups 25–64 and 80+ were for PGIs of self-rated health (HR 0.87, 95% CI 0.82; 0.93 for 25–64-year-olds, HR 1.00, 95% CI 0.94; 1.04 for 80+ year-olds, p=2*10<sup>-4</sup> for difference, p=0.006 after multiple-testing adjustment), ADHD (HR 1.14, 95% CI 1.08; 1.21 for 25–64-year-olds, HR 0.99, 95% CI 0.95; 1.03 for 80+ year-olds, p=7*10<sup>-4</sup> for difference, p=0.012 after multiple-testing adjustment) and depressive symptoms (HR 1.12, 95% CI 1.06; 1.18 for 25–64-year-olds, HR 1.00, 95% CI 0.96; 1.04 for 80+ year-olds, p=0.002 for difference, p=0.032 after multiple-testing adjustment). Additionally, the difference in HRs between these age groups achieved significance after multiple testing adjustment at the conventional 5% level for PGIs of cigarettes per day, educational attainment, and ever smoking.</p>
<p>We have also included the recent study by Argentieri et al. (2025) in the literature review, which was missing from our previous version. We appreciate the reference. Other references mentioned were already included in the previous version of the manuscript.</p>
<disp-quote content-type="editor-comment">
<p>(note that the small prediction accuracy of PGI in older age groups has been extensively studied, see Jiang, Holmes, and McVean, 2021, PLoS Genetics).</p>
</disp-quote>
<p>We would like to thank the reviewer for suggesting the relevant reference by Jiang et al. We have now expanded on the discussion of age-specific differences in the discussion section and included this reference.</p>
<disp-quote content-type="editor-comment">
<p>(2) The authors might check if PGI+Phenotype has improved performance over Phenotype only. This is similar to Model 2 in Table 1, but slightly different.</p>
</disp-quote>
<p>The reviewer raises an interesting angle to approach the analysis. We have now added an analysis assessing the information criteria and the significance of improvement between nested models in Supplementary table S8. All the tested PGI+phenotype models show improvement over the phenotype-only model that is statistically significant at all conventional levels when tested by likelihood-ratio tests between nested models . Additionally,  improvement was found when using Akaike and Bayesian (Schwarz) information criteria (albeit sometimes modest in size). We have added a passage in the results section briefly summarising this analysis:</p>
<p>Supplementary table S8 presents information criteria and significance tests on corresponding models. Models with PGI+phenotype (Models 2a–f) showed improvement over models with the phenotype only (Models 1a, 1c, 1e, 1g, 1i, 1k, with a p=0.0006 or lower) in terms of both Akaike information criterion (AIC) as well as Bayesian (Schwarz) information criterion (BIC) with a p=0.0006 or lower in all comparisons. The full Model 4 again showed improvement over the model with all PGIs jointly (Model 3b, with a p=0.0002 or p=0.00002, depending on continuous/categorical phenotype measurement), which had a lower AIC but not BIC.</p>
<disp-quote content-type="editor-comment">
<p><bold>Reviewer #2 (Public review):</bold></p>
<p>Summary:</p>
<p>This study provides a comprehensive evaluation of the association between polygenic indices (PGIs) for 35 lifestyle and behavioral traits and all-cause mortality, using data from Finnish population- and family-based cohorts. The analysis was stratified by sex, cause of death (natural vs. external), age at death, and participants' educational attainment. Additional analyses focused on the six most predictive PGIs, examining their independent associations after mutual adjustment and adjustment for corresponding directly measured baseline risk factors.</p>
<p>Strengths:</p>
<p>Large sample size with long-term follow-up.</p>
<p>Use of both population- and family-based analytical approaches to evaluate associations.</p>
<p>Weaknesses:</p>
<p>It is unclear whether the PGIs used for each trait represent the most current or optimal versions based on the latest GWAS data.</p>
</disp-quote>
<p>To our reading, this comment is closely related to the “recommendations for the author” number 3 by reviewer 2, and we thus address them together.</p>
<disp-quote content-type="editor-comment">
<p>If the Finnish data used in this study also contributed to the development of some of the PGIs, there is a risk of overestimating their associations with mortality due to overfitting or &quot;double-dipping.&quot; Similar inflation of effect sizes has been observed in studies using the UK Biobank, which is widely used for PGI construction.</p>
</disp-quote>
<p>To our reading, this comment is closely related to the “recommendations for the author” 4 by reviewer 2, and we thus address them together.</p>
<disp-quote content-type="editor-comment">
<p><bold>Recommendations for the authors:</bold></p>
<p><bold>Reviewer #1 (Recommendations for the authors):</bold></p>
<p>Specific comments:</p>
<p>(1) Cited reference 1 also investigated the PRS association with life span; cited reference 8 explains PRS association with healthy lifespan. Can authors be clearer about what is new in the context of these references? Specifically, what are the PGIs studied here that were not analyzed in the cited analyses?</p>
</disp-quote>
<p>Although some previous studies on the topic do exist, our analysis arguably has novelty in touching upon several unstudied or scarcely studied themes. These include:</p>
<p>A set of PGIs focusing on social, psychological, and behavioural phenotypes or PGIs for typically non-fatal health conditions.</p>
<p>An assessment of direct genetic effects/ confounding with a within-sibship design.</p>
<p>An assessment of potential heterogeneous effects by several socio-demographic characteristics.</p>
<p>An analysis of external causes of deaths (which can be hypothesised to be particularly relevant here, given the choice of our PGIs not focusing directly on typical causes of death).</p>
<p>A detailed assessment of the interplay of the most predictive PGIs with their corresponding phenotypes.</p>
<p>We have substantially revised the Introduction section focusing on making these novel contributions more explicit.</p>
<disp-quote content-type="editor-comment">
<p>(2) In the Methods section, it is not very clear why the authors specifically study the &quot;within-sibship&quot; samples. Is this for avoiding nurturing effects from parental genotypes or for controlling assortative mating? The authors should clarify the rationale behind the design.</p>
</disp-quote>
<p>The substance-related rationale behind this approach was briefly discussed in the Introduction section while in the Methods section, we focused more on the technical description of our analyses. However, it is certainly worthwhile to clarify to the reader why within-sibship methods have been used. The revised passage in the methods section now states:</p>
<p>“In addition to this population sample, we used a within-sibship analysis sample to assess the extent of direct and indirect genetic associations captured by the PGIs, as discussed in the introduction.”</p>
<disp-quote content-type="editor-comment">
<p>(3) Residual correlations of PGIs were no more than 0.050...&quot; As a minor comment, since PGIs is a noisy variable, the correlation would be low; however, I don't think there are better ways to evaluate Cox assumptions, and in many cases, this assumption is not correct for strong predictors.</p>
</disp-quote>
<p>Yes, these points are true. Overall, it is often implausible that empirical distributions exactly match distributional assumptions in statistical models. For example, it may not be realistic to expect that the mortality hazards across categories of independent variables stay exactly proportional during long mortality-follow-ups; some deviations from constant proportions are almost inevitable. However, there are reasonable grounds to argue that in case of moderate violations of the proportional hazards assumption, the estimates still remain interpretable for practical uses. They can be read as approximating average relative hazards over the study period (for discussion, see pages 42–47 in Allison P. 2014. Event history and survival analysis: Regression for longitudinal event data (second edition). Thousand Oaks: SAGE).</p>
<disp-quote content-type="editor-comment">
<p>(4) &quot;PGI of ADHD (HR=1.08 95%CI 1.04;1.11 among men; HR=1.01 95%CI 0.97;1.05 among women; p=0.012 for difference).&quot; Is this difference significant after multiple testing correction?</p>
</disp-quote>
<p>We have presented multiple-testing adjusted p-values together with nominal ones in this and in all other instances where they are mentioned in the text. Additionally, Supplementary tables S5–S6 present multiple-adjusted p-values for each PGIs studied.</p>
<disp-quote content-type="editor-comment">
<p>(5) &quot;Panel D displays that most PGIs had stronger associations with external (accidents, violent, suicide, and alcohol related deaths) than natural causes of death.&quot; Similar to the comment above, are there any results that are significantly different between internal and external?</p>
</disp-quote>
<p>We have added the p-values of those variables that had larger differences in the revised text. Quoting from the revised article: “The HR differences between external and natural causes of death were nominally significant at the conventional 5% level for cannabis use (p=0.016), drinks per week (p=0.028), left out of social activity (p=0.029), ADHD (p=0.031), BMI (p=0.035) and height (p=0.049), but none of these differences remained significant after adjusting for 35 multiple tests. “</p>
<disp-quote content-type="editor-comment">
<p>(6) Table 1: The effect of the phenotype is stronger than the PGI; this is expected as PGI is a weak predictor and can be considered as &quot;noised&quot; measurement of true genetic value (Becker 2021 Nature Human behavior). Is there a way to adjust for the impact of noise in PGI at tagging genetic value and compare if the PGI effect is different from the phenotype effect?</p>
</disp-quote>
<p>PGIs are certainly imperfect measures that contain a lot of noise. However, extracting new information from what is unknown is an extremely demanding exercise, and still further complicated for example, by that we do not know the exact benchmark of total genetic effect we should be aiming at. Different methods of heritability estimation, for instance, often give dramatically differing results – for reasons that are still up to scrutiny.</p>
<p>We are thus not familiar with a method that could achieve satisfactory answer for this challenging task.</p>
<disp-quote content-type="editor-comment">
<p><bold>Reviewer #2 (Recommendations for the authors):</bold></p>
<p>(3) Justification and Selection of PGIs:</p>
<p>For several traits, such as BMI, multiple polygenic indices (PGIs) are currently available. The criteria used to select specific PGIs for this study are not clearly described. A more systematic and reproducible approach-for example, leveraging metadata from the PGS Catalog-could strengthen the justification for PGI selection and enhance the study's generalizability.</p>
</disp-quote>
<p>There are numerous PGIs developed in the extensive GWAS literature, but a finite set of PGIs always needs to be chosen for any analysis. The rationale behind our decision to include every PGI from the repository of Becker et al. 2021 (full reference in the manuscript, see also <ext-link ext-link-type="uri" xlink:href="https://www.thessgac.org/pgi-repository">https://www.thessgac.org/pgi-repository</ext-link>) that was available for the Finnish data (including the possibility to exclude overlapping samples, see our response to the next comment for more discussion) was to provide rigorous analysis by limiting the researchers degrees of freedom in arbitrarily choosing PGIs. Although it would have been tempting to not use some PGIs that were not expected to substantially correlate with mortality, we believe that our conservative strategy increases the credibility of the reported p-values, particularly the multiple adjustment should now work as intended.</p>
<p>We also mention now this rationale when discussing the chosen PGIs in the methods section: “As the independent variables of main interest, we used 35 different PGIs in the Polygenic Index repository by Becker et al., which were mainly based on GWASes using UK Biobank and 23andMe, Inc. data samples, but also other data collections. They were tailored for the Finnish data, i.e., excluding overlapping individuals between the original GWAS and our analysis and performing linkage-disequilibrium adjustment. We used every single-trait PGI defined in the repository (except for subjective well-being, for which we were unable to obtain a meta-analysis version that excluded the overlapping samples). By limiting the researchers’ freedom in selecting the measures, this conservative strategy should increase the validity of our estimates, particularly with regards to multiple-testing adjusted p-values.”</p>
<disp-quote content-type="editor-comment">
<p>(4) Overlap Between PGI Training Data and Study Sample:</p>
<p>The authors should describe any overlap between the data used to develop the PGIs and the current study sample. If such overlap exists, it may lead to overestimation of effect sizes due to &quot;double-dipping.&quot; A discussion of this issue and its potential implications is warranted, as similar concerns have been raised in studies using UK Biobank data.</p>
</disp-quote>
<p>This is, fortunately, not a concern of our analysis. Overlapping samples were excluded in creating the PGIs that we used. We have now described this more clearly in the revised methods section.</p>
<disp-quote content-type="editor-comment">
<p>(1) Clarify the Methodology for Family-Based Cox Analysis:</p>
<p>It is unclear what specific method was used to perform Cox regression in the family-based analysis. Please provide additional methodological details. ”</p>
</disp-quote>
<p>We have described the method further and added an additional reference in the revision. The text now stands:</p>
<p>“We compared these models to the corresponding within-sibship models, using the sibship identifier as the strata variable. This method employs a sibship-specific (instead of a whole-sample-wide baseline hazard in the population models) baseline hazard, and corresponds to a fixed-effects model in some other regression frameworks (e.g., linear model with sibship-specific intercepts)”</p>
<disp-quote content-type="editor-comment">
<p>(2) Clarify Timing of Measured Risk Factors Relative to Follow-Up:</p>
<p>The main text should provide more detailed information regarding the timing of data collection for directly measured risk factors. Specifically, it should be clarified whether the measurements used correspond to the first available data for each individual after the start of follow-up, or if a different criterion was applied.</p>
</disp-quote>
<p>BMI, self-rated health, alcohol consumption and smoking status were measured at the baseline survey of each dataset. Education was registered as the highest completed degree up to the end of 2019. Depression was a composite of survey self-report (at the time of the baseline survey), as well as depression-related medicine purchases and hospitalizations over a two-year period before the start of the individual’s follow-up.</p>
<p>We have added more comprehensive information on the measurement of the phenotypes of interest in Supplementary table 2, including the timing of the measurement.</p>
</body>
</sub-article>
</article>